Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testing

American Journal of Clinical Pathology

Volumn 122, Issue 5, 2004, Pages 686-692

  Favaloro, Emmanuel J ^a,b   Soltani, Soma ^a   McDonald, Jane ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b Sydney West Area Health Service NSW Health   (Australia)

Author keywords

Diagnostic practice; Hemophilia; Hemostasis testing; Laboratory misdiagnosis; Test artifacts; von Wiliebrand factor; von Willebrand disease; von Willebrand disorder; vWD; vWF

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; PROTHROMBIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CENTRIFUGATION; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; ENVIRONMENTAL TEMPERATURE; FEMALE; HEMOPHILIA A; HUMAN; LABORATORY DIAGNOSIS; LOW TEMPERATURE; MALE; NORMAL HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

EID: 7244224989     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/E4947DG48TVY19C2     Document Type: Article

References (28)

1. Sadler JE, Mannucci PM, Berntorp E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84:160-174.
2. Sadler JE, Gralnick HR. Commentary: a new classification for von Willebrand disease. Blood. 1994;84:676-679.
3. Sadler JE, for the Subcommittee on von Willebrand Factor of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. A revised classification of von Willebrand disease. Thromb Haemost. 1994;71:520-525.
4. Ruggeri ZM. Structure and function of von Willebrand factor. Thromb Haemost. 1999;82:576-584.
5. Favaloro EJ. Appropriate laboratory assessment as a critical facet in the proper diagnosis and sub-classification of von Willebrand's disorder. Baillieres Best Pract Res Clin Haematol. 2001;14:299-319.
6. Favaloro EJ. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease. Blood Rev. 1999;13:185-204.
7. Favaloro EJ. von Willebrand factor (vWF) collagen binding (activity) assay (vWF:CBA) in the diagnosis of von Willebrand's disorder (vWD): a 15-year journey. Semin Thromb Hemost. 2002;28:191-202.
8. Favaloro EJ, Mohammed A, Coombs R, et al. Filtered plasma as a potential cause of clinical misdiagnosis: inappropriate testing in a haematology laboratory. Br J Biomed Sci. 1995;52:243-248.
9. Favaloro EJ, Mehrabani PA, Koutts J. Laboratory assessment of von Willebrand factor: altered interpretation of laboratory data, and altered diagnosis of von Willebrand's disease, as influenced by the use of different vWF assays and assay conditions. Clin Appl Thromb Hemost. 1997;3:110-118.
10. Favaloro EJ, Nair SC, Forsyth CJ. Collection and transport of samples for laboratory testing in von Willebrand's disease (vWD): time for a reappraisal [letter]? Thromb Haemost. 2001;86:1589-1590.
11. Favaloro EJ, Bonar R, Sioufi J, et al, on behalf of the RCPA QAP in Haematology Haemostasis Committee. Laboratory diagnosis of von Willebrand disorder: current practice in the Southern Hemisphere. Am J Clin Pathol. 2003;119:882-893.
12. Arkin CF, Bowue EJW, Carroll JJ, et al. Collection, Transport, and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays; Approved Guideline. 3rd ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 1998.
13. Mohammed A, Mehrabani PA, Coombs R, et al. The MDA-180 coagulation analyser: a laboratory evaluation. Pathology. 1997;29:176-183.
14. Favaloro EJ, Grispo L, Dinale A, et al. von Willebrand's disease: laboratory investigation using an improved functional assay for von Willebrand factor. Pathology. 1993;25:152-158.
15. Favaloro EJ, Koutts J. Laboratory assays for von Willebrand factor: relative contribution to the diagnosis of von Willebrand's disease. Pathology. 1997;29:385-391.
16. Favaloro EJ. Collagen binding assay for von Willebrand factor (vWF:CBA): detection of von Willebrand's disease (vWD), and discrimination of vWD subtypes, depends on collagen source. Thromb Haemost. 2000;83:127-135.
17. Favaloro EJ, Henniker A, Facey D, et al. Discrimination of von Willebrand's disease (vWD) subtypes: direct comparison of von Willebrand factoncollagen binding activity/assay (vWF:CBA) with monoclonal antibody (MAB) based ELISA vWF-detection systems. Thromb Haemost. 2000;84:541-547.
18. Arkin CF, Adcock DM, Ernst DJ, et al. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays; Approved Guideline. 4th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 2003.
19. Farrugia A, Street A, Douglas S, et al. Stabilization of von Willebrand factor in banked blood by leucocyte depletion. Transfus Med. 1993;3:51-57.
20. Lloyd JV, Tunbridge LJ, Rodgers SE, et al. Destruction of ristocetin cofactor by coagulation at 4°C. Thromb Res. 1985;37:659-667.
21. Obert B, Tout H, Veyradier A, et al. Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF. Thromb Haemost. 1999;82:1382-1385.
22. Gerritsen HE, Turecek PL, Schwan HP, et al. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost. 1999;82:1386-1389.
23. Xie L, Chesterman CN, Hogg PJ. Reduction of von Willebrand factor by endothelial cells. Thromb Haemost. 2000;84:506-513.
24. O'Donnell J, Laffan MA. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med. 2001;11:343-351.
25. Haley E, Babar N, Ritter C, et al. Effect of ABO blood group on the collagen-binding assay for von Willebrand factor. Am J Hematol. 2002;71:229-231.
26. Miller CH, Haff E, Platt SJ, et al. Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost. 2003;1:2191-2197.
27. Bowen DJ. An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost. 2003;1:33-40.
28. Rodeghiero F. von Willebrand disease: still an intriguing disorder in the era of molecular medicine. Haemophilia. 2002;8:292-300.